Paolo Massucco

A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Andrea Bertotti, Giorgia Migliardi, Francesco Galimi et al. · Cancer Discovery · 2011 · 938 citations · Full text

Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas

Giorgia Migliardi, Francesco Sassi, Davide Torti et al. · Clinical Cancer Research · 2012 · 192 citations · Full text

Asymptomatic Colorectal Cancer with Un-Resectable Liver Metastases: Immediate Colorectal Resection or Up-Front Systemic Chemotherapy?

Andrea Muratore, Daria Zorzi, Hedayat Bouzari et al. · Annals of Surgical Oncology · 2006 · 177 citations

Surgical Oncology, Hepatology, Asymptomatic Colorectal Cancer +12

Pancreatic Resections after Chemoradiotherapy for Locally Advanced Ductal Adenocarcinoma: Analysis of Perioperative Outcome and Survival

Paolo Massucco, Lorenzo Capussotti, A. Magnino et al. · Annals of Surgical Oncology · 2006 · 138 citations

Surgical Oncology, Pancreatic Cancer, Gastrointestinal Oncology +7

Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations

Francesco Galimi, Davide Torti, Francesco Sassi et al. · Clinical Cancer Research · 2011 · 127 citations · Full text